TTNP - Titan Pharmaceutical...About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $3.51 | Open | |
| Volume | 514 | Market Cap | 23.92M |
| Yield | Last Dividend |
| Maxim Group Upgrades Titan Pharma As 'Pr... | 02/18/21 |
| Titan Pharmaceuticals, Inc. (NASDAQ: TTNP ) is set to begin a new phase, according to Maxim Group, after undergoing several changes in strategy, manag... | |
| EFFECT - TITAN PHARMACEUTICALS INC (0000... | 02/08/21 |
| Accepted 2021-02-08 00:15:26 Documents Thank you for supporting Stocks News Feed. As an Amazon affiliate, we earn from qualifying purchases. 1 Effecti... | |
| Positive Early Study Results Help Pave W... | 02/01/21 |
| SOUTH SAN FRANCISCO, Calif., Feb. 1, 2021 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today announced that studies of its kappa opioid ... | |
| Titan Pharmaceuticals Announces Pricing ... | 01/15/21 |
| SOUTH SAN FRANCISCO, Calif., Jan. 15, 2021 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today announced it has entered into a securities... | |
| Titan Pharmaceuticals Regains Compliance... | 12/16/20 |
| SOUTH SAN FRANCISCO, Calif., Dec. 16, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("the "Company") today announced that on Decembe... | |
| Zoom Video Communications, CureVac leads... | 12/01/20 |
| Titan Pharmaceuticals (NASDAQ:TTNP) -15%. Tuniu (NASDAQ:TOUR) -15% on Q3 earnings release. Medigus (NASDAQ:MDGS) -15% on appointment of new finance ch... | |
| Thinking about buying stock in Titan Pha... | 12/01/20 |
| NEW YORK, Dec. 1, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TTNP, MRNA, MBRX, CRBP, and ALT. To see how InvestorsOb... | |
| 66 Biggest Movers From Friday | 11/23/20 |
| Gainers Kaixin Auto Holdings (NASDAQ: KXIN ) shares jumped 103.3% to close at $6.06 on Friday. FTS International Inc (NYSE: FTSI ) jumped 57% to close... | |
| Titan Pharmaceuticals Reports Third Quar... | 11/16/20 |
| SOUTH SAN FRANCISCO, Calif., Nov. 16, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today reported financ... | |
| Thinking about buying stock in Fuel Tech... | 11/11/20 |
| NEW YORK, Nov. 11, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for FTEK, NIO, TTNP, SNDL, and ACB. To see how InvestorsOb... | |
| The Daily Biotech Pulse: Bluebird Bio Pl... | 11/05/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 4) Abbo... | |
| The Daily Biotech Pulse: Aurinia Pulls T... | 11/03/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 2) Bio-... | |
| Titan Pharmaceuticals Completes Debt Set... | 11/02/20 |
| SOUTH SAN FRANCISCO, Calif., Nov. 2, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) today announced the completion of its agreement to... | |
| Thinking about buying stock in Pinterest... | 10/29/20 |
| NEW YORK, Oct. 29, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PINS, NOK, TTNP, SHIP, and AMD. To see how InvestorsOb... | |
| Titan Pharmaceuticals Announces Pricing ... | 10/28/20 |
| SOUTH SAN FRANCISCO, Calif., Oct. 28, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today announced the pricing of an underwritten p... | |
| Titan Pharmaceuticals Announces Debt Set... | 10/26/20 |
| SOUTH SAN FRANCISCO, Calif. , Oct. 26, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP ), a company developing proprietary therapeutics... | |
| Global Opioid Use Disorder Market (Covid... | 10/22/20 |
| Data Bridge Market Research has recently added a concise research on the Global Opioid Use Disorder Market- Industry Trends and Forecast to 2026. A re... | |
| The Daily Biotech Pulse: Prothena Progre... | 10/21/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 20) Ail... | |
| The Daily Biotech Pulse: Amarin Vascepa ... | 10/16/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 15) Ami... | |
| Titan Pharmaceuticals Provides a Strateg... | 10/15/20 |
| SOUTH SAN FRANCISCO, Calif., Oct. 15, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) ("Titan" or the "Company") today announced a stra... | |
| Titan's Probuphine?? Commercialization P... | 09/15/20 |
| SOUTH SAN FRANCISCO, Calif., Sept. 15, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that... | |
| Titan Pharmaceuticals Provides Update To... | 09/14/20 |
| SOUTH SAN FRANCISCO, Calif., Sept. 14, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today provided an up... | |
| Titan Pharmaceuticals Reports Second Qua... | 08/14/20 |
| SOUTH SAN FRANCISCO, Calif., Aug. 14, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) ("Titan" or the "Company") today ??? | |
| Thinking about buying stock in SINTX Tec... | 06/24/20 |
| NEW YORK, June 24, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SINT, KTOV, TTNP, TMUS, and NIO. To see how InvestorsO... | |
| Titan Pharmaceuticals And Indegene Enter... | 06/24/20 |
| SAN FRANCISCO, June 24, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has entered... | |
| Titan Pharmaceuticals Launches Virtual R... | 06/16/20 |
| /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has initiated a fully-virtual Probuphine... | |
| Titan Pharmaceuticals, Inc. (TTNP): Q4 2... | 03/30/20 |
| ??? Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) reported a loss of $0.08 per share in the fourth quarter of 2019, in line with Wall Street expectation.... | |
| Titan Pharmaceuticals Announces Pricing ... | 01/07/20 |
| SOUTH SAN FRANCISCO, Calif. , Jan. 7, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP ) today announced it has entered into a securitie... | |
| Titan Pharmaceuticals Appoints Dr. Kate ... | 12/30/19 |
| SOUTH SAN FRANCISCO, Calif., Dec. 30, 2019 /PRNewswire/ -- Titan Pharmaceuticals, Inc. today announced that at its recent annual stockholders meeting,... | |
| Titan Pharmaceuticals Reports Third Quar... | 11/14/19 |
| SOUTH SAN FRANCISCO, Calif., Nov. 14, 2019 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today reported financial results for the third q... | |
| Buy rating | 02/18/21 |
| Maxim Group upgrades from Hold to Buy rating and announces Price Target of $11.00 | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Tech Trades | Tech Trades | 82.00 % | Follow |
| Swing Trading Cheap Stocks <~ $10 | Michael S. DeVries | 70.00 % | Follow |
| Burdeshaw Investing | Matthew Burdeshaw | 56.00 % | Subscribe |
| Tech and Bio Swing Trades | Matthew Burdeshaw | 46.00 % | Subscribe |
| R R Holding Company | Roland Van Rij | 0.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
